Ivarmacitinib sulfate Base gel(Jiangsu Hengrui Medicine)

硫酸艾玛昔替尼碱凝胶（江苏恒瑞医药）

Report date: 2026/01/27 10:16:56
NME

Base Information

Drug NameIvarmacitinib sulfate Base gel(Jiangsu Hengrui Medicine)
Drug Alias NameSHR0302Base gelSHR0302碱凝胶SHR0302 base
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsSignal transducer and activator of transcription 3 inhibitors
TargetsTyrosine-protein kinase JAK1Signal transducer and activator of transcription 3
Therapy Area/IndicationsVitiligo
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsVitiligo
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG